What the African Medicines Agency Means for Africa’s Health & Investment Future скачать в хорошем качестве

What the African Medicines Agency Means for Africa’s Health & Investment Future

Africa has taken a major step toward controlling its own health and pharmaceutical future with the official launch of the African Medicines Agency (AMA). Announced in Mombasa during the SCoMRA VII conference, the AMA marks a turning point for regulatory harmonisation, drug safety, pharmaceutical manufacturing, and continent-wide clinical research. In this video, we break down what the AMA’s launch means for: ✔ CEOs and founders in the health, biotech, and FMCG sectors ✔ Investors and venture capital firms seeking new African opportunities ✔ Policymakers and innovators in pharmaceutical regulation ✔ Entrepreneurs building Africa-focused health solutions From Africa’s unparalleled genetic diversity to the urgent need for high-quality, locally relevant medical products, the AMA could reshape not only African healthcare—but global biomedical standards. Watch to discover the strategic implications, market opportunities, and what comes next for Africa’s health-product ecosystem. #AfricanMedicinesAgency #AMAfrica #AfricaBusiness #AfricaHealth#HealthcareInnovation #PharmaAfrica #AfricaInvestments #BiotechAfrica #AfricaRising #SCoMRA #DrugRegulation #ClinicalTrialsAfrica #PharmaceuticalManufacturing #HealthTechAfrica #RegulatoryHarmonisation #BiotechInvesting #PublicHealthAfrica #MedicalProductsRegulation Subscribe for weekly insights on Africa’s business, innovation, and investment landscape. Find out more about our events: https://www.empowerafrica.com/events/ Join our network: https://network.empowerafrica.com/join/ Find out more about Empower Africa: https://www.empowerafrica.com/